Cargando…

A redesigned follitropin alfa pen injector for infertility: results of a market research study

BACKGROUND: The purpose of this study was to evaluate patient-learning and nurse-teaching experiences when using a redesigned prefilled, ready-to-use follitropin alfa pen injector. METHODS: Seventy-three UK women of reproductive age either administering daily treatment with self-injectable gonadotro...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbotts, Carole, Salgado-Braga, Cristiana, Audibert-Gros, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140313/
https://www.ncbi.nlm.nih.gov/pubmed/21792303
http://dx.doi.org/10.2147/PPA.S21421
_version_ 1782208544893829120
author Abbotts, Carole
Salgado-Braga, Cristiana
Audibert-Gros, Céline
author_facet Abbotts, Carole
Salgado-Braga, Cristiana
Audibert-Gros, Céline
author_sort Abbotts, Carole
collection PubMed
description BACKGROUND: The purpose of this study was to evaluate patient-learning and nurse-teaching experiences when using a redesigned prefilled, ready-to-use follitropin alfa pen injector. METHODS: Seventy-three UK women of reproductive age either administering daily treatment with self-injectable gonadotropins or about to start gonadotropin treatment for infertility (aged 24–47 years; 53 self-injection-experienced and 20 self-injection-naïve) and 28 nurses from UK infertility clinics were recruited for the study. Following instruction, patients and nurses used the redesigned follitropin alfa pen to inject water into an orange and completed questionnaires to evaluate their experiences with the pen immediately after the simulated injections. RESULTS: Most (88%, n = 64) patients found it easy to learn how to use the pen. Among injection-experienced patients, 66% (n = 35) agreed that the redesigned pen was easier to learn to use compared with their current method and 70% (n = 37) also said they would prefer its use over current devices for all injectable fertility medications. All nurses considered the redesigned pen easy to learn and believed it would be easy to teach patients how to use. Eighty-six percent (n = 24) of the nurses thought it was easy to teach patients to determine the remaining dose to be dialed and injected in a second pen if the initial dose was incomplete. Compared with other injection devices, 96% (n = 27) thought it was “much easier” to “as easy” to teach patients to use the redesigned pen. Based on ease of teaching, 68% (n = 19) of nurses would choose to teach the pen in preference to any other injection method. Almost all (93%, n = 26) nurses considered that having the same pen format for a range of injectable gonadotropins would facilitate teaching and learning self-injection. CONCLUSION: In this market research study with infertile patients and infertility nurses, the redesigned follitropin alfa pen was perceived as easy to learn, easy to teach how to use, and well accepted.
format Online
Article
Text
id pubmed-3140313
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31403132011-07-26 A redesigned follitropin alfa pen injector for infertility: results of a market research study Abbotts, Carole Salgado-Braga, Cristiana Audibert-Gros, Céline Patient Prefer Adherence Review BACKGROUND: The purpose of this study was to evaluate patient-learning and nurse-teaching experiences when using a redesigned prefilled, ready-to-use follitropin alfa pen injector. METHODS: Seventy-three UK women of reproductive age either administering daily treatment with self-injectable gonadotropins or about to start gonadotropin treatment for infertility (aged 24–47 years; 53 self-injection-experienced and 20 self-injection-naïve) and 28 nurses from UK infertility clinics were recruited for the study. Following instruction, patients and nurses used the redesigned follitropin alfa pen to inject water into an orange and completed questionnaires to evaluate their experiences with the pen immediately after the simulated injections. RESULTS: Most (88%, n = 64) patients found it easy to learn how to use the pen. Among injection-experienced patients, 66% (n = 35) agreed that the redesigned pen was easier to learn to use compared with their current method and 70% (n = 37) also said they would prefer its use over current devices for all injectable fertility medications. All nurses considered the redesigned pen easy to learn and believed it would be easy to teach patients how to use. Eighty-six percent (n = 24) of the nurses thought it was easy to teach patients to determine the remaining dose to be dialed and injected in a second pen if the initial dose was incomplete. Compared with other injection devices, 96% (n = 27) thought it was “much easier” to “as easy” to teach patients to use the redesigned pen. Based on ease of teaching, 68% (n = 19) of nurses would choose to teach the pen in preference to any other injection method. Almost all (93%, n = 26) nurses considered that having the same pen format for a range of injectable gonadotropins would facilitate teaching and learning self-injection. CONCLUSION: In this market research study with infertile patients and infertility nurses, the redesigned follitropin alfa pen was perceived as easy to learn, easy to teach how to use, and well accepted. Dove Medical Press 2011-06-28 /pmc/articles/PMC3140313/ /pubmed/21792303 http://dx.doi.org/10.2147/PPA.S21421 Text en © 2011 Abbotts et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Abbotts, Carole
Salgado-Braga, Cristiana
Audibert-Gros, Céline
A redesigned follitropin alfa pen injector for infertility: results of a market research study
title A redesigned follitropin alfa pen injector for infertility: results of a market research study
title_full A redesigned follitropin alfa pen injector for infertility: results of a market research study
title_fullStr A redesigned follitropin alfa pen injector for infertility: results of a market research study
title_full_unstemmed A redesigned follitropin alfa pen injector for infertility: results of a market research study
title_short A redesigned follitropin alfa pen injector for infertility: results of a market research study
title_sort redesigned follitropin alfa pen injector for infertility: results of a market research study
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140313/
https://www.ncbi.nlm.nih.gov/pubmed/21792303
http://dx.doi.org/10.2147/PPA.S21421
work_keys_str_mv AT abbottscarole aredesignedfollitropinalfapeninjectorforinfertilityresultsofamarketresearchstudy
AT salgadobragacristiana aredesignedfollitropinalfapeninjectorforinfertilityresultsofamarketresearchstudy
AT audibertgrosceline aredesignedfollitropinalfapeninjectorforinfertilityresultsofamarketresearchstudy
AT abbottscarole redesignedfollitropinalfapeninjectorforinfertilityresultsofamarketresearchstudy
AT salgadobragacristiana redesignedfollitropinalfapeninjectorforinfertilityresultsofamarketresearchstudy
AT audibertgrosceline redesignedfollitropinalfapeninjectorforinfertilityresultsofamarketresearchstudy